Skip to main content

Dr Snehal Patel judging Forbes’ 30 Under 30 Asia 2017

CEO and Co-Founder, Dr Snehal Patel, will be judging Forbes’ 30 Under 30 Asia 2017 for the Healthcare and Science category.

Forbes’ 30 Under 30 list features 30 inspirational change-makers under the age of 30 from 24 countries across Asia Pacific for each of the 10 categories, ranging from entertainment, sports, finance, to healthcare and science.
Honorees for the healthcare and science category include top scientists who published breakthrough medical research to successful entrepreneurs in the digital health industry, bringing quality healthcare to millions of people.
Dr Snehal Patel is one of the three judges who put together Forbes’ 30 Under 30 Asia 2017 Healthcare & Science list
For instance, Yuki Shimahara, an honoree from Japan, developed LPixel, a software and platform utilizing artificial intelligence to interpret and store medical imaging such as X-rays, CT scans and MRIs to help diagnose diseases. Another honoree, Liu Yuchen, this time from China, is a surgeon and researcher who developed DNA molecular robots that are programmable to detect and treat cancer cells.
Dr Snehal joins two other leading healthcare experts as judges for this esteemed category. They are Sonny Vu, founder and CEO of Misfit; and Steve Monaghan, an investor and chairman of Gen.Life Limited based in Hong Kong.
Dr Snehal’s participation fits well within the MyDoc journey as we aim to improve the quality and efficiency of the existing healthcare delivery system, providing a conducive digital ecosystem for patients and healthcare providers to interact. Similar to MyDoc, this year’s honorees, in their own ways, are committed to pushing the boundaries of innovation to provide better health as well as healthcare services for everyone. It is our privilege to support these young inspirational individuals and companies and we look forward to seeing them grow even more.

Popular posts from this blog

How to manage outbreaks in the face of a healthcare crisis

Dr. Snehal Patel, CEO and Co-Founder, MyDoc When the World Health Organisation (WHO) declared the recent 2019-nCoV Novel Coronavirus outbreak a Public Health Emergency of International Concern (PHEIC), I was in Bangkok speaking to a few business partners about expanding our digital healthcare services in the country. Naturally, in Thailand, there were a lot of concerns surrounding the 2019-nCoV coronavirus, more commonly referred to as the Wuhan virus. Ever since the first reported case outside of China was announced on the 13th of January in Thailand, our clinical team has been closely monitoring the situation. When it hit Singapore 10 days later, just before the Chinese New Year break, our team was not preparing for the festivities, but rather preparing for a crisis. We knew our digital healthcare platform had the capability to respond quickly to the epidemic that was fast turning into a pandemic. Image credit: Getty Images/XiaoLu Chu First, let me quash some rumour

Healthtech start-up MyDoc raises USD5.2 Million

Singapore,  21  September 2017 –  MyDoc , a Singapore-based regional healthtech start-up, has raised US$5.2 million in a Series A funding round. The investment was led by  UST Global , a California-headquartered leading digital technology services company. Other investors include cross-border early stage venture capital firm  Wavemaker Partners . Led by US-based UST Global; Wavemaker Partners also participating Funding will develop MyDoc@Work, a fully-automated corporate healthcare platform, and to develop health insurtech solutions as well as to enter new markets MyDoc provides companies with an easy-to-use digital health platform that integrates key aspects of healthcare – connecting patients, healthcare professionals, corporates, pharmacies, health data and insurers. Current clients include Asia’s largest insurers such as AIA, AXA and Aetna and other partners including the Health Promotion Board (HPB), Guardian Pharmacy, as well as individual general practitioner cli

I Am And I Will: 5 steps to start reducing your cancer risk

Globally, Cancer is the 2nd leading cause of death worldwide 9.6 million people die from cancer every year The number of deaths from cancer will double in the next 10 yrs (by 2030) According to the Singapore Cancer Registry Annual Registry Report 2015, 35 people are diagnosed with cancer every day in Singapore Men: Highest incidence of colorectal cancer followed by lung cancer Women: Highest incidence of breast cancer followed by colorectal cancer Good news: Prevention is better than cure At least 1/3rd of common cancers are preventable 3.7 million lives can be saved yearly through prevention, early detection and timely treatment. Source: www.preventcancer.org Know your risk Chances that you have a higher risk of cancer are partly unavoidable such as age and genetic predisposition. Organ transplants, AIDS or HIV infection, as well as immunosuppressant drugs for other medical conditions, can weaken your immune systems, which increases your risk of cancer. Exp